{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T11:11:41Z","timestamp":1784545901117,"version":"3.55.0"},"reference-count":171,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T00:00:00Z","timestamp":1743379200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81803980"],"award-info":[{"award-number":["81803980"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2020ZG09"],"award-info":[{"award-number":["2020ZG09"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2022JKZZW03"],"award-info":[{"award-number":["2022JKZZW03"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008990","name":"Science and Technology Department of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03214"],"award-info":[{"award-number":["2024C03214"]}],"id":[{"id":"10.13039\/501100008990","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017599","name":"Science and Technology Program of Zhejiang Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017599","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.autrev.2025.103809","type":"journal-article","created":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T19:27:15Z","timestamp":1743449235000},"page":"103809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Decoding tryptophan: Pioneering new frontiers in systemic lupus erythematosus"],"prefix":"10.1016","volume":"24","author":[{"given":"Fugang","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanqun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keda","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2025.103809_bb0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/s41584-021-00668-1","article-title":"Global epidemiology of systemic lupus erythematosus","volume":"17","author":"Barber","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103809_bb0010","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","article-title":"Tryptophan metabolism in health and disease","volume":"35","author":"Xue","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/j.autrev.2025.103809_bb0015","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf9794","article-title":"Kynurenines: tryptophan\u2019s metabolites in exercise, inflammation, and mental health","volume":"357","author":"Cervenka","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.autrev.2025.103809_bb0020","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41573-019-0016-5","article-title":"Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond","volume":"18","author":"Platten","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.autrev.2025.103809_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coi.2020.12.001","article-title":"Tryptophan and indole metabolism in immune regulation","volume":"70","author":"Fiore","year":"2021","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0030","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","article-title":"Gut microbiota regulation of tryptophan metabolism in health and disease","volume":"23","author":"Agus","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.autrev.2025.103809_bb0035","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s42003-024-07360-6","article-title":"Hyperphenylalaninemia and serotonin deficiency in Dnajc12-deficient mice","volume":"7","author":"Cao","year":"2024","journal-title":"Commun Biol"},{"key":"10.1016\/j.autrev.2025.103809_bb0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13287-024-03728-x","article-title":"Transcriptomic profiling across human serotonin neuron differentiation via the FEV reporter system","volume":"15","author":"Li","year":"2024","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.autrev.2025.103809_bb0045","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1007\/s10571-023-01324-w","article-title":"Melatonin and health: insights of melatonin action, biological functions, and associated disorders","volume":"43","author":"Ahmad","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/j.autrev.2025.103809_bb0050","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40261-019-00793-6","article-title":"Melatonin and multiple sclerosis: from plausible Neuropharmacological mechanisms of action to experimental and clinical evidence","volume":"39","author":"Yeganeh Salehpour","year":"2019","journal-title":"Clin Drug Investig"},{"key":"10.1016\/j.autrev.2025.103809_bb0055","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41467-018-05470-4","article-title":"Microbial tryptophan catabolites in health and disease","volume":"9","author":"Roager","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103809_bb0060","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.immuni.2013.08.003","article-title":"Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22","volume":"39","author":"Zelante","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2025.103809_bb0065","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.immuni.2014.06.014","article-title":"Symbiotic bacterial metabolites regulate gastrointestinal barrier function via the xenobiotic sensor PXR and toll-like receptor 4","volume":"41","author":"Venkatesh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2025.103809_bb0070","article-title":"Modulation of immunity by tryptophan microbial metabolites","volume":"10","author":"Li","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.autrev.2025.103809_bb0075","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/0961203320929746","article-title":"Effect of indole-3-carbinol on transcriptional profiling of wound-healing genes in macrophages of systemic lupus erythematosus patients: an RNA sequencing assay","volume":"29","author":"Eghbalpour","year":"2020","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103809_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0125109","article-title":"Type I interferon-mediated skewing of the serotonin synthesis is associated with severe disease in systemic lupus erythematosus","volume":"10","author":"Lood","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2025.103809_bb0085","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00726-023-03353-7","article-title":"Altered kynurenine pathway metabolism and association with disease activity in patients with systemic lupus","volume":"55","author":"Eryavuz Onmaz","year":"2023","journal-title":"Amino Acids"},{"key":"10.1016\/j.autrev.2025.103809_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1515\/CCLM.2010.105","article-title":"Simultaneous determination of serum tryptophan metabolites in patients with systemic lupus erythematosus by high performance liquid chromatography with fluorescence detection","volume":"48","author":"Xiang","year":"2010","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0095","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0171-2985(00)80079-0","article-title":"Enhanced tryptophan degradation in systemic lupus erythematosus","volume":"201","author":"Widner","year":"2000","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2025.103809_bb0100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2249.2007.03480.x","article-title":"Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season","volume":"150","author":"Pertovaara","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2017-000254","article-title":"Kynurenine pathway is altered in patients with SLE and associated with severe fatigue","volume":"5","author":"\u00c5kesson","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104241","article-title":"Microbiota-mediated skewing of tryptophan catabolism modulates CD4+ T cells in lupus-prone mice","volume":"25","author":"Brown","year":"2022","journal-title":"iScience"},{"key":"10.1016\/j.autrev.2025.103809_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159384","article-title":"Metabolic profiling of systemic lupus erythematosus and comparison with primary Sj\u00f6gren\u2019s syndrome and systemic sclerosis","volume":"11","author":"Bengtsson","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2025.103809_bb0120","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.3389\/fimmu.2020.02138","article-title":"Fecal metabolites were altered, identified as biomarkers and correlated with disease activity in patients with systemic lupus erythematosus in a GC-MS-based metabolomics study","volume":"11","author":"Yan","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0125","doi-asserted-by":"crossref","first-page":"976","DOI":"10.3389\/fimmu.2019.00976","article-title":"Fecal metabolomics and potential biomarkers for systemic lupus erythematosus","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0130","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/1040841X.2013.813901","article-title":"The shikimate pathway: review of amino acid sequence, function and three-dimensional structures of the enzymes","volume":"41","author":"Mir","year":"2015","journal-title":"Crit Rev Microbiol"},{"key":"10.1016\/j.autrev.2025.103809_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aax2220","article-title":"Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice","volume":"12","author":"Choi","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0140","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2347728","article-title":"Human gut-associated Bifidobacterium species salvage exogenous indole, a uremic toxin precursor, to synthesize indole-3-lactic acid via tryptophan","volume":"16","author":"Yong","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.autrev.2025.103809_bb0145","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.3390\/foods11203302","article-title":"The effect of Indole-3-lactic acid from Lactiplantibacillus plantarum ZJ316 on human intestinal microbiota in vitro","volume":"11","author":"Zhou","year":"2022","journal-title":"Foods"},{"key":"10.1016\/j.autrev.2025.103809_bb0150","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/08916930600918472","article-title":"Hydroxyl radical modification of human serum albumin generated cross reactive antibodies","volume":"39","author":"Rasheed","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103809_bb0155","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijbiomac.2020.01.295","article-title":"Impact of endogenous stress on albumin structure in systemic lupus erythematosus (SLE) patients","volume":"151","author":"Arif","year":"2020","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.autrev.2025.103809_bb0160","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.57.3.496","article-title":"The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus","volume":"57","author":"Ainiala","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.autrev.2025.103809_bb0165","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/art.40933","article-title":"Cognitive dysfunction in systemic lupus erythematosus: a case for initiating trials","volume":"71","author":"Kello","year":"2019","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103809_bb0170","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","article-title":"New insights into the immunopathogenesis of systemic lupus erythematosus","volume":"12","author":"Tsokos","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103809_bb0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103809_bb0180","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/nm1101-1189","article-title":"A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus","volume":"7","author":"DeGiorgio","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0185","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/mp.2009.116","article-title":"CSF concentrations of brain tryptophan and kynurenines during immune stimulation with IFN-alpha: relationship to CNS immune responses and depression","volume":"15","author":"Raison","year":"2010","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.autrev.2025.103809_bb0190","first-page":"343","article-title":"The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies","volume":"45","author":"Inam","year":"2023","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.autrev.2025.103809_bb0195","doi-asserted-by":"crossref","first-page":"15150","DOI":"10.3390\/ijms160715150","article-title":"Behavioral deficits are accompanied by immunological and neurochemical changes in a mouse model for neuropsychiatric lupus (NP-SLE)","volume":"16","author":"Li","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0200","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s12035-015-9090-9","article-title":"The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases","volume":"53","author":"Morris","year":"2016","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.autrev.2025.103809_bb0205","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fmolb.2019.00007","article-title":"The synthesis of Kynurenic acid in mammals: an updated kynurenine aminotransferase structural KATalogue","volume":"6","author":"Rossi","year":"2019","journal-title":"Front Mol Biosci"},{"key":"10.1016\/j.autrev.2025.103809_bb0210","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/jnc.14043","article-title":"Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression-like behavior","volume":"142","author":"Eskelund","year":"2017","journal-title":"J Neurochem"},{"key":"10.1016\/j.autrev.2025.103809_bb0215","first-page":"850","article-title":"Quinolinic acid in patients with systemic lupus erythematosus and neuropsychiatric manifestations","volume":"23","author":"Vogelgesang","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103809_bb0220","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.neuropharm.2016.08.003","article-title":"The kynurenine pathway and the brain: challenges, controversies and promises","volume":"112","author":"Schwarcz","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.autrev.2025.103809_bb0225","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","article-title":"Serotonin, tryptophan metabolism and the brain-gut-microbiome axis","volume":"277","author":"O\u2019Mahony","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.autrev.2025.103809_bb0230","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000270","article-title":"Interferon pathway in SLE: one key to unlocking the mystery of the disease","volume":"6","author":"R\u00f6nnblom","year":"2019","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0235","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/art.37821","article-title":"Disease mechanisms in rheumatology--tools and pathways: plasmacytoid dendritic cells and their role in autoimmune rheumatic diseases","volume":"65","author":"Eloranta","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103809_bb0240","first-page":"246","article-title":"Type I interferon signature in systemic lupus erythematosus","volume":"16","author":"Bezalel","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2025.103809_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000559","article-title":"Quinolinic acid, a kynurenine\/tryptophan pathway metabolite, associates with impaired cognitive test performance in systemic lupus erythematosus","volume":"8","author":"Anderson","year":"2021","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0250","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43331-3","article-title":"Raman spectroscopy and mass spectrometry identifies a unique group of epidermal lipids in active discoid lupus erythematosus","volume":"13","author":"Holtkamp","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103809_bb0255","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000808","article-title":"Associations between circulating interferon and kynurenine\/tryptophan pathway metabolites: support for a novel potential mechanism for cognitive dysfunction in SLE","volume":"9","author":"Anderson","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0260","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1200\/JCO.2003.04.070","article-title":"Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program","volume":"21","author":"Morrow","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.autrev.2025.103809_bb0265","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2165\/00023210-200519020-00002","article-title":"Neuropsychiatric adverse effects of interferon-alpha: recognition and management","volume":"19","author":"Raison","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.autrev.2025.103809_bb0270","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.4049\/jimmunol.2000260","article-title":"Mood disorder in systemic lupus erythematosus induced by Antiribosomal P protein antibodies associated with decreased serum and brain tryptophan","volume":"206","author":"Cho","year":"2021","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0275","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/rheumatology\/kead402","article-title":"Pathogenetic associations of anti-ribosomal P protein antibody titres and their subclasses in patients with systemic lupus erythematosus","volume":"63","author":"Kaneko","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2025.103809_bb0280","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/s41590-019-0386-1","article-title":"Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways","volume":"20","author":"Der","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0285","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2478\/v10039-010-0015-6","article-title":"Kynurenine pathway - a new link between endothelial dysfunction and carotid atherosclerosis in chronic kidney disease patients","volume":"55","author":"Pawlak","year":"2010","journal-title":"Adv Med Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0290","doi-asserted-by":"crossref","DOI":"10.1177\/1178646920954882","article-title":"Kynurenine pathway in chronic kidney disease: what\u2019s old, what\u2019s new, and what\u2019s next?","volume":"13","author":"Mor","year":"2020","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.autrev.2025.103809_bb0295","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108448","article-title":"Podocyte injury caused by indoxyl sulfate, a uremic toxin and aryl-hydrocarbon receptor ligand","volume":"9","author":"Ichii","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2025.103809_bb0300","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s00726-024-03418-1","article-title":"Identification of amino acids metabolomic profiling in human plasma distinguishes lupus nephritis from systemic lupus erythematosus","volume":"56","author":"Guo","year":"2024","journal-title":"Amino Acids"},{"key":"10.1016\/j.autrev.2025.103809_bb0305","doi-asserted-by":"crossref","first-page":"9555","DOI":"10.1038\/s41598-024-60217-0","article-title":"Urinary metabolomic profiling of a cohort of Colombian patients with systemic lupus erythematosus","volume":"14","author":"Rojo-S\u00e1nchez","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103809_bb0310","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.clinbiochem.2010.06.008","article-title":"3-hydroxyanthranilic acid is independently associated with monocyte chemoattractant protein-1 (CCL2) and macrophage inflammatory protein-1beta (CCL4) in patients with chronic kidney disease","volume":"43","author":"Pawlak","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.autrev.2025.103809_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.103355","article-title":"Predicting lupus membranous nephritis using reduced picolinic acid to tryptophan ratio as a urinary biomarker","volume":"24","author":"Anekthanakul","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.autrev.2025.103809_bb0320","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/ard-2023-223929","article-title":"Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares","volume":"82","author":"Azzouz","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0325","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1136\/annrheumdis-2018-214856","article-title":"Lupus nephritis is linked to disease-activity associated expansions and immunity to a gut commensal","volume":"78","author":"Azzouz","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0330","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.chom.2014.09.001","article-title":"Discovery and characterization of gut microbiota decarboxylases that can produce the neurotransmitter tryptamine","volume":"16","author":"Williams","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.autrev.2025.103809_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101798","article-title":"Bacterially derived tryptamine increases mucus release by activating a host receptor in a mouse model of inflammatory bowel disease","volume":"23","author":"Bhattarai","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.autrev.2025.103809_bb0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106922","article-title":"CD4 T cells differentially express cellular machinery for serotonin signaling, synthesis, and metabolism","volume":"88","author":"Wu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.autrev.2025.103809_bb0345","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood-2006-10-052787","article-title":"Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor","volume":"109","author":"Le\u00f3n-Ponte","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2025.103809_bb0350","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.autrev.2008.12.014","article-title":"Histologic features of cutaneous lupus erythematosus","volume":"8","author":"Baltaci","year":"2009","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103809_bb0355","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.3390\/cells11111742","article-title":"Exogenous ceramide serves as a precursor to endogenous ceramide synthesis and as a modulator of keratinocyte differentiation","volume":"11","author":"Shin","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2025.103809_bb0360","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1073\/pnas.1117736109","article-title":"Tolerance to apoptotic cells is regulated by indoleamine 2,3-dioxygenase","volume":"109","author":"Ravishankar","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2025.103809_bb0365","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jaad.2010.07.050","article-title":"Indoleamine 2,3-dioxygenase-expressing myeloid dendritic cells and macrophages in infectious and noninfectious cutaneous granulomas","volume":"65","author":"von Bubnoff","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2025.103809_bb0370","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1124\/pr.114.009001","article-title":"The aryl hydrocarbon receptor in barrier organ physiology, immunology, and toxicology","volume":"67","author":"Esser","year":"2015","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.autrev.2025.103809_bb0375","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1016\/j.jaci.2018.11.036","article-title":"A tryptophan metabolite of the skin microbiota attenuates inflammation in patients with atopic dermatitis through the aryl hydrocarbon receptor","volume":"143","author":"Yu","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0380","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jdermsci.2020.10.004","article-title":"Activation of aryl hydrocarbon receptor in Langerhans cells by a microbial metabolite of tryptophan negatively regulates skin inflammation","volume":"100","author":"Liu","year":"2020","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0385","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/jid.2010.269","article-title":"The aryl hydrocarbon receptor mediates UVB radiation-induced skin tanning","volume":"131","author":"Jux","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2025.103809_bb0390","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jdermsci.2018.04.010","article-title":"Tryptophan photo-product FICZ upregulates AHR\/MEK\/ERK-mediated MMP1 expression: implications in anti-fibrotic phototherapy","volume":"91","author":"Murai","year":"2018","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0395","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1002\/eji.201445144","article-title":"Ultraviolet light converts propranolol, a nonselective \u03b2-blocker and potential lupus-inducing drug, into a proinflammatory AhR ligand","volume":"45","author":"Dorgham","year":"2015","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0400","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/cei.12288","article-title":"Interferon (IFN)-\u03b3-mediated inflammation and the kynurenine pathway in relation to bone mineral density: the Hordaland health study","volume":"176","author":"Apalset","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0405","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/jbmr.3224","article-title":"Kynurenine, a tryptophan metabolite that accumulates with age, induces bone loss","volume":"32","author":"Refaey","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.autrev.2025.103809_bb0410","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/nm1107","article-title":"4-1BB-mediated immunotherapy of rheumatoid arthritis","volume":"10","author":"Seo","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0415","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.humimm.2008.08.283","article-title":"Inhibitory CD8+ T cells in autoimmune disease","volume":"69","author":"Suzuki","year":"2008","journal-title":"Hum Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0420","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4137\/IJTR.S14084","article-title":"Tryptophan and kynurenic acid may produce an amplified effect in central fatigue induced by chronic sleep disorder","volume":"7","author":"Yamashita","year":"2014","journal-title":"Int J Tryptophan Res"},{"key":"10.1016\/j.autrev.2025.103809_bb0425","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.brainres.2017.09.002","article-title":"Tryptophan circuit in fatigue: from blood to brain and cognition","volume":"1675","author":"Yamashita","year":"2017","journal-title":"Brain Res"},{"key":"10.1016\/j.autrev.2025.103809_bb0430","article-title":"Metabolic biomarkers in Midtrimester maternal plasma can accurately predict adverse pregnancy outcome in patients with SLE","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2025.103809_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.739430","article-title":"Human complement C4B Allotypes and deficiencies in selected cases with autoimmune diseases","volume":"12","author":"Zhou","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0440","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1016\/j.febslet.2011.04.032","article-title":"Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?","volume":"585","author":"Burn","year":"2011","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2025.103809_bb0445","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bbrc.2010.06.091","article-title":"Expression of functional GPR35 in human iNKT cells","volume":"398","author":"Fallarini","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2025.103809_bb0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102870","article-title":"Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies","volume":"132","author":"Li","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103809_bb0455","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","article-title":"T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy","volume":"16","author":"Sharabi","year":"2020","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.autrev.2025.103809_bb0460","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0465","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"IDO expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0470","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2567.2005.02224.x","article-title":"Indoleamine 2,3 dioxygenase and human leucocyte antigen-G inhibit the T-cell alloproliferative response through two independent pathways","volume":"116","author":"Le Rond","year":"2005","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2025.103809_bb0475","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.immuni.2005.03.013","article-title":"GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase","volume":"22","author":"Munn","year":"2005","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2025.103809_bb0480","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20200012","article-title":"Metabolic targets for treatment of autoimmune diseases","volume":"2","author":"Piranavan","year":"2020","journal-title":"Immunometabolism"},{"key":"10.1016\/j.autrev.2025.103809_bb0485","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s11306-015-0772-0","article-title":"Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin","volume":"11","author":"Perl","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.autrev.2025.103809_bb0490","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.2174\/092986712803833353","article-title":"Emerging concepts on inhibitors of indoleamine 2,3-dioxygenase in rheumatic diseases","volume":"19","author":"Filippini","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.autrev.2025.103809_bb0495","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.176.11.6752","article-title":"The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells","volume":"176","author":"Fallarino","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0500","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1084\/jem.20020052","article-title":"Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites","volume":"196","author":"Terness","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0505","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.cdd.4401073","article-title":"T cell apoptosis by tryptophan catabolism","volume":"9","author":"Fallarino","year":"2002","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.autrev.2025.103809_bb0510","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.tips.2023.04.006","article-title":"Modulation of T cells by tryptophan metabolites in the kynurenine pathway","volume":"44","author":"Stone","year":"2023","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0515","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa0835","article-title":"Normalization of CD4+ T cell metabolism reverses lupus","volume":"7","author":"Yin","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0520","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/s41467-018-04366-7","article-title":"Single cell analysis of kynurenine and system L amino acid transport in T cells","volume":"9","author":"Sinclair","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2025.103809_bb0525","article-title":"Endosome traffic modulates pro-inflammatory signal transduction in CD4+ T cells-implications for the pathogenesis of systemic lupus erythematosus","volume":"24","author":"Park","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0530","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1111\/j.1365-2362.2011.02491.x","article-title":"Indoleamine 2,3-dioxygenase-expressing peripheral cells in rheumatoid arthritis and systemic lupus erythematosus: a cross-sectional study","volume":"41","author":"Furuzawa-Carballeda","year":"2011","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.autrev.2025.103809_bb0535","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1096\/fj.04-3228fje","article-title":"Indolamine 2,3-dioxygenase is expressed in the CNS and down-regulates autoimmune inflammation","volume":"19","author":"Kwidzinski","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.autrev.2025.103809_bb0540","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/j.1468-1331.2010.03257.x","article-title":"Multiple sclerosis, seizures, and antiepileptics: role of IL-18, IDO, and melatonin","volume":"18","author":"Anderson","year":"2011","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.autrev.2025.103809_bb0545","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.949603","article-title":"Fine-tuning of regulatory T cells is indispensable for the metabolic steatosis-related hepatocellular carcinoma: a review","volume":"10","author":"Riaz","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.autrev.2025.103809_bb0550","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/imm.13600","article-title":"AHR\/TET2\/NT5E axis downregulation is associated with the risk of systemic lupus erythematosus and its progression","volume":"168","author":"Cheng","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2025.103809_bb0555","doi-asserted-by":"crossref","first-page":"5396","DOI":"10.4049\/jimmunol.181.8.5396","article-title":"The indoleamine 2,3-dioxygenase pathway is essential for human plasmacytoid dendritic cell-induced adaptive T regulatory cell generation","volume":"181","author":"Chen","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0560","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.it.2018.10.010","article-title":"The aryl hydrocarbon receptor: connecting immunity to the microenvironment","volume":"39","author":"Shinde","year":"2018","journal-title":"Trends Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0565","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.autrev.2014.10.001","article-title":"Cell-based therapies for systemic lupus erythematosus","volume":"14","author":"Liao","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2025.103809_bb0570","doi-asserted-by":"crossref","first-page":"6578","DOI":"10.3390\/ijms24076578","article-title":"Advances in the pathogenesis and treatment of systemic lupus erythematosus","volume":"24","author":"Accapezzato","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0575","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1177\/0961203308089410","article-title":"Systemic lupus erythematosus patients have increased number of circulating plasmacytoid dendritic cells, but decreased myeloid dendritic cells with deficient CD83 expression","volume":"17","author":"Jin","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.autrev.2025.103809_bb0580","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1136\/annrheumdis-2015-208055","article-title":"Activated T cells enhance interferon-\u03b1 production by plasmacytoid dendritic cells stimulated with RNA-containing immune complexes","volume":"75","author":"Leonard","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0585","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1172\/JCI124466","article-title":"Monoclonal antibody targeting BDCA2 ameliorates skin lesions in systemic lupus erythematosus","volume":"129","author":"Furie","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2025.103809_bb0590","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1084\/jem.20132620","article-title":"Early, transient depletion of plasmacytoid dendritic cells ameliorates autoimmunity in a lupus model","volume":"211","author":"Rowland","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0595","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s12276-023-01028-7","article-title":"Immune regulation through tryptophan metabolism","volume":"55","author":"Seo","year":"2023","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0600","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.molmed.2008.11.006","article-title":"TGF-beta and kynurenines as the key to infectious tolerance","volume":"15","author":"Belladonna","year":"2009","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0605","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.3389\/fimmu.2019.01973","article-title":"Engagement of nuclear coactivator 7 by 3-Hydroxyanthranilic acid enhances activation of aryl hydrocarbon receptor in Immunoregulatory dendritic cells","volume":"10","author":"Gargaro","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0610","doi-asserted-by":"crossref","first-page":"10774","DOI":"10.1073\/pnas.1504276112","article-title":"The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity","volume":"112","author":"Ravishankar","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2025.103809_bb0615","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/08916934.2018.1494161","article-title":"Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: a crucial role for aryl hydrocarbon receptor","volume":"51","author":"Mohammadi","year":"2018","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103809_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1339250","article-title":"Neutrophils isolated from systemic lupus erythematosus patients exhibit a distinct functional phenotype","volume":"15","author":"Jog","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0625","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000709","article-title":"Immune complex-driven neutrophil activation and BAFF release: a link to B cell responses in SLE","volume":"9","author":"Wang","year":"2022","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0630","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/annrheumdis-2018-213181","article-title":"REDD1\/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)","volume":"78","author":"Frangou","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0635","doi-asserted-by":"crossref","first-page":"772","DOI":"10.3389\/fimmu.2019.00772","article-title":"Innate immune cells\u2019 contribution to systemic lupus erythematosus","volume":"10","author":"Herrada","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0640","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.649693","article-title":"Neutrophils in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus: same foe different M.O","volume":"12","author":"Fresneda Alarcon","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0645","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.3389\/fimmu.2019.02428","article-title":"Blue and long-wave ultraviolet light induce in vitro neutrophil extracellular trap (NET) formation","volume":"10","author":"Neubert","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0650","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaut.2012.05.012","article-title":"TLR9 drives the development of transitional B cells towards the marginal zone pathway and promotes autoimmunity","volume":"39","author":"Guerrier","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103809_bb0655","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1002\/art.38742","article-title":"Impaired suppressive capacity of activation-induced regulatory B cells in systemic lupus erythematosus","volume":"66","author":"Gao","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2025.103809_bb0660","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1007\/s00726-014-1766-3","article-title":"Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1","volume":"46","author":"Pantouris","year":"2014","journal-title":"Amino Acids"},{"key":"10.1016\/j.autrev.2025.103809_bb0665","doi-asserted-by":"crossref","first-page":"342","DOI":"10.31138\/mjr.230124.uos","article-title":"Use of glucocorticoids in SLE: a clinical approach","volume":"35","author":"Martin-Iglesias","year":"2024","journal-title":"Mediterr J Rheumatol"},{"key":"10.1016\/j.autrev.2025.103809_bb0670","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0675","first-page":"743","article-title":"Cyclophosphamide and mycophenolate mofetil as induction therapy in lupus nephritis","volume":"55","author":"Bo\u017ei\u0107","year":"2024","journal-title":"Scr Med (Brno)"},{"key":"10.1016\/j.autrev.2025.103809_bb0680","doi-asserted-by":"crossref","DOI":"10.3329\/cmoshmcj.v22i1.67831","article-title":"Risk assessment of cyclophosphamide and mycophenolate mofetil after induction treatment of lupus nephritis: a single center quasi-experimental study","author":"Kamal","year":"2023","journal-title":"Chattagram Maa-o-Shishu Hosp Med Coll J"},{"key":"10.1016\/j.autrev.2025.103809_bb0685","series-title":"Effect of rituximab versus mycophenolate mofetil or cyclophosphamide as control in lupus nephritis: a meta-analysis","author":"Nicola","year":"2023"},{"key":"10.1016\/j.autrev.2025.103809_bb0690","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2023-eular.5648","article-title":"Ab0499 step-down approach in methotrexate use for the treatment of rheumatoid arthritis (stemetra): a pilot study demonstrating efficacy and safety of short-term high dose methotrexate","author":"Pendolino","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0695","article-title":"Prevalence of methotrexate-induced lung involvement in psoriasis patients","author":"Khan","year":"2023","journal-title":"Pak J Med Health Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/1756-185X.70021","article-title":"The 2024 APLAR consensus on the management of lupus nephritis","volume":"28","author":"Mok","year":"2025","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0705","doi-asserted-by":"crossref","DOI":"10.17925\/RMD.2022.1.1.32","article-title":"Belimumab: a BAFF-specific inhibitor for the treatment of systemic lupus erythematosus and lupus nephritis","author":"Tanaka","year":"2022","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2025.103809_bb0710","first-page":"11","article-title":"Progress of rituximab in the treatment of systemic lupus erythematosus and lupus nephritis","author":"Mo","year":"2024","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2025.103809_bb0715","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/ijms26030929","article-title":"Advances in targeted therapy for systemic lupus erythematosus: current treatments and novel approaches","volume":"26","author":"Saegusa","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0720","doi-asserted-by":"crossref","first-page":"6670","DOI":"10.1073\/pnas.97.12.6670","article-title":"Genetic reconstitution of systemic lupus erythematosus immunopathology with polycongenic murine strains","volume":"97","author":"Morel","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.autrev.2025.103809_bb0725","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-12-394299-9.00004-7","article-title":"Mapping lupus susceptibility genes in the NZM2410 mouse model","volume":"115","author":"Morel","year":"2012","journal-title":"Adv Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0730","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/jcp.26819","article-title":"In vivo study: Th1-Th17 reduction in pristane-induced systemic lupus erythematosus mice after treatment with tolerogenic Lactobacillus probiotics","volume":"234","author":"Mardani","year":"2018","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2025.103809_bb0735","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.696074","article-title":"Lactobacillus acidophilus supplementation exerts a synergistic effect on tacrolimus efficacy by modulating Th17\/Treg balance in lupus-prone mice via the SIGNR3 pathway","volume":"12","author":"Kim","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0740","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1228754","article-title":"Limosilactobacillus reuteri in immunomodulation: molecular mechanisms and potential applications","volume":"14","author":"Luo","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0745","doi-asserted-by":"crossref","first-page":"G824","DOI":"10.1152\/ajpgi.00107.2019","article-title":"Lactobacillus reuteri DSM 17938 feeding of healthy newborn mice regulates immune responses while modulating gut microbiota and boosting beneficial metabolites","volume":"317","author":"Liu","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.autrev.2025.103809_bb0750","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells--a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0755","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1126\/science.aah5825","article-title":"Lactobacillus reuteri induces gut intraepithelial CD4+CD8\u03b1\u03b1+ T cells","volume":"357","author":"Cervantes-Barragan","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.autrev.2025.103809_bb0760","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1080\/08916934.2020.1777282","article-title":"Feeding lactobacilli impacts lupus progression in (NZBxNZW)F1 lupus-prone mice by enhancing immunoregulation","volume":"53","author":"Manirarora","year":"2020","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2025.103809_bb0765","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s12602-020-09668-1","article-title":"Heat-killed Lactobacillus reuteri GMNL-263 inhibits systemic lupus erythematosus-induced cardiomyopathy in NZB\/W F1 mice","volume":"13","author":"Yeh","year":"2021","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10.1016\/j.autrev.2025.103809_bb0770","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1017\/S0007114517001039","article-title":"Lactobacillus paracasei GMNL-32, Lactobacillus reuteri GMNL-89 and L. reuteri GMNL-263 ameliorate hepatic injuries in lupus-prone mice","volume":"117","author":"Hsu","year":"2017","journal-title":"Br J Nutr"},{"key":"10.1016\/j.autrev.2025.103809_bb0775","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.chom.2018.11.009","article-title":"A diet-sensitive commensal Lactobacillus strain mediates TLR7-dependent systemic autoimmunity","volume":"25","author":"Zegarra-Ruiz","year":"2019","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.autrev.2025.103809_bb0780","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/imm.12806","article-title":"Autologous tolerogenic dendritic cells derived from monocytes of systemic lupus erythematosus patients and healthy donors show a stable and immunosuppressive phenotype","volume":"152","author":"Obreque","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2025.103809_bb0785","doi-asserted-by":"crossref","first-page":"7865","DOI":"10.1002\/jcb.27203","article-title":"Generation of tolerogenic dendritic cells using Lactobacillus rhamnosus and Lactobacillus delbrueckii as tolerogenic probiotics","volume":"119","author":"Esmaeili","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.autrev.2025.103809_bb0790","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/cells8101291","article-title":"Current paradigms of Tolerogenic dendritic cells and clinical implications for systemic lupus erythematosus","volume":"8","author":"Ritprajak","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.autrev.2025.103809_bb0795","first-page":"1509","article-title":"Inhibitory effects of tolerogenic probiotics on migratory potential of lupus patient-derived DCs","volume":"24","author":"Esmaeili","year":"2021","journal-title":"Iran J Basic Med Sci"},{"key":"10.1016\/j.autrev.2025.103809_bb0800","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102856","article-title":"Dendritic cells in systemic lupus erythematosus: from pathogenesis to therapeutic applications","volume":"132","author":"Liu","year":"2022","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2025.103809_bb0805","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/imm.13119","article-title":"Tolerogenic dendritic cell transfer ameliorates systemic lupus erythematosus in mice","volume":"158","author":"Funes","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2025.103809_bb0810","doi-asserted-by":"crossref","first-page":"5713","DOI":"10.4049\/jimmunol.1500277","article-title":"Amino acid metabolism inhibits antibody-driven kidney injury by inducing autophagy","volume":"194","author":"Chaudhary","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0815","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/annrheumdis-2021-221835","article-title":"Serum interferon-\u03b1 levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity","volume":"81","author":"Chasset","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0820","article-title":"Evaluation of the efficacy and safety of anifrolumab in moderate-to-severe systemic lupus erythematosus","volume":"16","author":"Cingireddy","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.autrev.2025.103809_bb0825","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/ard-2023-225445","article-title":"Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials","volume":"83","author":"Baker","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0830","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/1744666X.2023.2268284","article-title":"Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosus","volume":"20","author":"Gensous","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2025.103809_bb0835","series-title":"Clinical trials with ifn blockers","author":"Blockers","year":"2023"},{"key":"10.1016\/j.autrev.2025.103809_bb0840","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/annrheumdis-2019-216379","article-title":"IFN-\u03b1 kinoid in systemic lupus erythematosus: results from a phase IIb, randomised, placebo-controlled study","volume":"79","author":"Houssiau","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2025.103809_bb0845","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1046\/j.1526-0968.2003.00010.x","article-title":"Immusorba TR and PH","volume":"7","author":"Hirata","year":"2003","journal-title":"Ther Apher Dial"},{"key":"10.1016\/j.autrev.2025.103809_bb0850","article-title":"The development of immunosorbents for the treatment of systemic lupus erythematosus via hemoperfusion","volume":"9","author":"Yu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.autrev.2025.103809_bb0855","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.transci.2017.08.011","article-title":"Immunoadsorption using Immusorba TR and PH","volume":"56","author":"Hirano","year":"2017","journal-title":"Transfus Apher Sci"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000692?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997225000692?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:14:05Z","timestamp":1778620445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997225000692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":171,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S1568997225000692"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103809","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Decoding tryptophan: Pioneering new frontiers in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2025.103809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"103809"}}